Clinical laboratories were hit hard when COVID-19 erupted in the United States last spring. Labs scrambled to develop and ramp up COVID-19 testing while facing PPE shortages, the need to keep staff infection free, and sharp drops in revenue due to patients delaying routine care and elective procedures. In this interview, Dr. Jon Genzen, COO of ARUP Laboratories, describes a few of the many ways ARUP quickly and successfully adapted to this unfamiliar and challenging environment.